| [1] |
Ankrom MA, Shapiro JR. Paget's disease of bone (osteitis deformans)[J]. J Am Geriatr Soc, 1998, 46: 1025-1033.
|
| [2] |
Takata S, Hashimoto J, Nakatsuka K, et al. Guidelines for diagnosis and management of Paget's disease of bone in Japan[J]. J Bone Miner Metab, 2006, 24(5): 359-367.
|
| [3] |
Paget J. On a form of chronic inflammation of bones (osteitis deformans)[J]. Med Chir Trans, 1877, 60: 37-64.
|
| [4] |
Numan MS, Amiable N, Brown JP, et al. Paget's disease of bone: an osteoimmunological disorder?[J]. Drug Des Devel Ther, 2015, 9: 4695-4707.
|
| [5] |
Gu JM, Zhang ZL, Zhang H, et al. Thirteen Chinese patients with sporadic Paget's disease of bone: clinical features, SQSTM1 mutation identification, and functional analysis[J]. J Bone Miner Metab, 2012, 30(5): 525-533.
|
| [6] |
Hepherd R, Jennings PE. Paget's disease of the skull causing hyperp- rolactinemia and erectile dysfunction: a case report[J]. J Med Case Rep, 2008, 2: 234.
|
| [7] |
刘红光，卢明花，曹庆选. 畸形性骨炎CT诊断[J]. 实用放射学杂志, 2002, 18(1): 63-64.
|
| [8] |
Wat WZ, Cheung WS, Lau TW. A case series of Paget's disease of bone in Chinese[J]. Hong Kong Med J, 2013, 19(3): 242-248.
|
| [9] |
Hori S, Kurimoto M, Umemura K, et al. Syringomyelia associated with Paget disease of the skull[J]. Neurol Med Chir (Tokyo), 2013, 53(2): 115-118.
|
| [10] |
范保萍，李丽丽，栗夏莲. 畸形性骨炎1例报道[J]. 中华骨质疏松和骨矿盐疾病杂志, 2016, 9(2): 183-185.
|
| [11] |
Shaker JL. Paget's disease of bone: a review of epidemiology, patho-physiology and management[J]. Ther Adv Musculoskelet Dis, 2009, 1(2): 107-125.
|
| [12] |
Fernandes AM, Pedreira DG, Lopes P, et al. Osteolitic and osteoblastic lesions of the skull[J]. BMJ Case Rep, 2013, 2013: bcr2013201228.
|
| [13] |
Kravets I. Paget's disease of bone: diagnosis and treatment[J]. Am J Med, 2018, 131(11): 1298-1303.
|
| [14] |
Bou Antoun M, Kemel S, Polivka M, et al. The lucent (CT) and enhancing (MR) rim, a sign of Paget's disease of the skull: case report[J]. Skeletal Radiol, 2018, 47(11): 1567-1570.
|
| [15] |
Ferraz-de-Souza B, Martin RM, Correa PH. Symptomatic intracranial hypertension and prolonged hypocalcemia following treatment of Paget's disease of the skull with zoledronic acid[J]. J Bone Miner Metab, 2013, 31(3): 360-365.
|
| [16] |
Condon JR. Possible role for glucagon in the control of Paget's disease of bone[J]. Postgrad Med J, 2019, 95(1120): 85-90.
|
| [17] |
Reid IR, Sharma S, Kalluru R, et a1. Treatment of Paget's disease of bone with denosumab: case report and literature review[J]. Calcif Tissue Int, 2016, 99(3): 322-325.
|
| [18] |
Hansen MF, Seton M, Merchant A. Osteosarcoma in Paget's disease of bone[J]. J Bone Miner Res, 2006, 21(Suppl 2): P58-P63.
|
| [19] |
Rousière M, Michou L, Cornélis F, et al. Paget's disease of bone[J]. Best Pract Res Clin Rheumatol, 2003, 17(6): 1019-1041.
|